CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company...
12 Health Care Stocks Moving In Thursday's After-Market Session
CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset sale
Caredex | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 131.95 M
From AI Pivots to Reverse Splits: U.S. Micro-Caps Embrace Aggressive Restructuring in July
The 2026 Micro-Catalyst Market: Why Precision Genomics and Premium Tea Are Moving the Needle
CareDx director Hannah Valantine disposes of common shares worth $1.04 million